法规动态

FDA、EMA、TGA 及全球法规动态

#lamotrigine ×

2026年9月10日•1 分钟阅读

FDA Approves Chartwell Molecular Lamotrigine Tablet ANDA077783

FDA has approved ANDA 077783 for oral lamotrigine tablets (25‑200 mg) submitted by Chartwell Molecular, with multiple labeling submissions cleared.